PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cmajCMAJ Information for AuthorsCMAJ Home Page
 
CMAJ. 1996 July 1; 155(1): 25–37.
PMCID: PMC1487869

Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.

Abstract

OBJECTIVE: To develop a set of comprehensive, standardized evidence-based guidelines for the assessment and treatment of acute asthma in adults in the emergency setting. OPTIONS: The use of medications was evaluated by class, dose, route, onset of action and optimal mode of delivery. The use of objective measurements and clinical features to assess response to therapy were evaluated in relation to the decision to admit or discharge the patient or arrange for follow-up care. OUTCOMES: Control of symptoms and disease reflected in hospital admission rates, frequency of treatment failures following discharge, resolution of symptoms and improvement of spirometric test results. EVIDENCE: Previous guidelines, articles retrieved through a search of MEDLINE, emergency medical abstracts and information from members of the expert panel were reviewed by members of the Canadian Association of Emergency Physicians (CAEP) and the Canadian Thoracic Society. Where evidence was not available, consensus was reached by the expert panel. The resulting guidelines were reviewed by members of the parent organizations. VALUES: The evidence-based methods and values of the Canadian Task Force on the Periodic Health Examination were used. BENEFITS, HARMS AND COSTS: As many as 80% of the approximate 400 deaths from asthma each year in Canada are felt to be preventable. The use of guidelines, aggressive emergency management and consistent use of available options at discharge are expected to decrease the rates of unnecessary hospital admissions and return visits to emergency departments because of treatment failures. Substantial decreases in costs are expected from the use of less expensive drugs, or drug delivery systems, fewer hospital admissions and earlier return to full activity after discharge. RECOMMENDATIONS: Beta2-agonists are the first-line therapy for the management of acute asthma in the emergency department (grade A recommendation). Bronchodilators should be administered by the inhaled route and titrated using objective and clinical measures of airflow limitation (grade A). Metered-dose inhalers are preferred to wet nebulizers, and a chamber (spacer device) is recommended for severe asthma (grade A). Anticholinergic therapy should be added to beta 2 agonist therapy in severe and life-threatening cases and may be considered in cases of mild to moderate asthma (grade A). Aminophylline is not recommended for use in the first 4 hours of therapy (grade A). Ketamine and succinylcholine are recommended for rapid sequence intubation in life-threatening cases (grade B). Adrenaline (administered subcutaneously or intravenously), salbutamol (administered intravenously) and anesthetics (inhaled) are recommended as alternatives to conventional therapy in unresponsive life-threatening cases (grade B). Severity of airflow limitation should be determined according to the forced expiratory volume at 1 second or the peak expiratory flow rate, or both, before and after treatment and at discharge (grade A). Consideration for discharge should be based on both spirometric test results and assessment of clinical risk factors for relapse (grade A). All patients should be considered candidates for systemic corticosteroid therapy at discharge (grade A). Those requiring corticosteroid therapy should be given 30 to 60 mg of prednisone orally (or equivalent) per day for 7 to 14 days; no tapering is required (grade A). Inhaled corticosteroids are an integral component of therapy and should be prescribed for all patients receiving oral corticosteroid therapy at discharge (grade A). Patients should be given a discharge treatment plan and clear instructions for follow-up care (grade C). VALIDATION: The guidelines share the same principles of those from the British Thoracic Society and the National Institutes of Health. Two specific validation initiatives have been undertaken: (a) several Canadian centres have been involved in the collection of comprehensive administrative data to assess compliance and outcome measures and (b) a survey of Canadian emergency physicians conducted to gather baseline informaton of treatment patterns, was conducted before development of the guidelines and will be repeated to re-evaluate emergency management of asthma.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Jackson R, Sears MR, Beaglehole R, Rea HH. International trends in asthma mortality: 1970 to 1985. Chest. 1988 Nov;94(5):914–918. [PubMed]
  • Mao Y, Semenciw R, Morrison H, MacWilliam L, Davies J, Wigle D. Increased rates of illness and death from asthma in Canada. CMAJ. 1987 Oct 1;137(7):620–624. [PMC free article] [PubMed]
  • Wilkins K, Mao Y. Trends in rates of admission to hospital and death from asthma among children and young adults in Canada during the 1980s. CMAJ. 1993 Jan 15;148(2):185–190. [PMC free article] [PubMed]
  • Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child. 1989 Oct;64(10):1452–1456. [PMC free article] [PubMed]
  • Johnson AJ, Nunn AJ, Somner AR, Stableforth DE, Stewart CJ. Circumstances of death from asthma. Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1870–1872. [PMC free article] [PubMed]
  • Benatar SR. Fatal asthma. N Engl J Med. 1986 Feb 13;314(7):423–429. [PubMed]
  • Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deaths from asthma. Thorax. 1986 Nov;41(11):833–839. [PMC free article] [PubMed]
  • Robin ED. Death from bronchial asthma. Chest. 1988 Mar;93(3):614–618. [PubMed]
  • Barnes PJ. Poorly perceived asthma. Thorax. 1992 Jun;47(6):408–409. [PMC free article] [PubMed]
  • FitzGerald JM, Hargreave FE. The assessment and management of acute life-threatening asthma. Chest. 1989 Apr;95(4):888–894. [PubMed]
  • Fitzgerald JM, Hargreave FE. Acute asthma: emergency department management and prospective evaluation of outcome. CMAJ. 1990 Mar 15;142(6):591–595. [PMC free article] [PubMed]
  • Kuo E, Kesten S. A retrospective comparative study of in-hospital management of acute severe asthma: 1984 vs 1989. Chest. 1993 Jun;103(6):1655–1661. [PubMed]
  • Westerman DE, Benatar SR, Potgieter PD, Ferguson AD. Identification of the high-risk asthmatic patient. Experience with 39 patients undergoing ventilation for status asthmaticus. Am J Med. 1979 Apr;66(4):565–572. [PubMed]
  • Dales RE, Kerr PE, Schweitzer I, Reesor K, Gougeon L, Dickinson G. Asthma management preceding an emergency department visit. Arch Intern Med. 1992 Oct;152(10):2041–2044. [PubMed]
  • Reed S, Diggle S, Cushley MJ, Sleet RA, Tattersfield AE. Assessment and management of asthma in an accident and emergency department. Thorax. 1985 Dec;40(12):897–902. [PMC free article] [PubMed]
  • Bucknall CE, Robertson C, Moran F, Stevenson RD. Management of asthma in hospital: a prospective audit. Br Med J (Clin Res Ed) 1988 Jun 11;296(6637):1637–1639. [PMC free article] [PubMed]
  • Garrett JE, Mulder J, Veale A. Trends in the use of an urban accident and emergency department by asthmatics. N Z Med J. 1988 May 25;101(846):253–255. [PubMed]
  • Chidley KE, Wood-Baker R, Town GI, Sleet RA, Holgate ST. Reassessment of asthma management in an accident and emergency department. Respir Med. 1991 Sep;85(5):373–377. [PubMed]
  • Ebden P, Carey OJ, Quinton D, Cookson JB. A study of acute asthma in the accident and emergency department. Br J Dis Chest. 1988 Apr;82(2):162–167. [PubMed]
  • Woolcock A, Rubinfeld AR, Seale JP, Landau LL, Antic R, Mitchell C, Rea HH, Zimmerman P. Thoracic society of Australia and New Zealand. Asthma management plan, 1989. Med J Aust. 1989 Dec 4;151(11-12):650–653. [PubMed]
  • Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol. 1990 Jun;85(6):1098–1111. [PubMed]
  • Corbridge TC, Hall JB. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med. 1995 May;151(5):1296–1316. [PubMed]
  • Rossing TH, Fanta CH, Goldstein DH, Snapper JR, McFadden ER., Jr Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis. 1980 Sep;122(3):365–371. [PubMed]
  • Becker AB, Nelson NA, Simons FE. Inhaled salbutamol (albuterol) vs injected epinephrine in the treatment of acute asthma in children. J Pediatr. 1983 Mar;102(3):465–469. [PubMed]
  • Fanta CH, Rossing TH, McFadden ER., Jr Emergency room of treatment of asthma. Relationships among therapeutic combinations, severity of obstruction and time course of response. Am J Med. 1982 Mar;72(3):416–422. [PubMed]
  • Fanta CH, Rossing TH, McFadden ER., Jr Treatment of acute asthma. Is combination therapy with sympathomimetics and methylxanthines indicated? Am J Med. 1986 Jan;80(1):5–10. [PubMed]
  • Ikeda K, Nakashima A, Ikeda A, Fujita H, Tsukino M. [A clinical trial to determine whether intravenous aminophylline is indispensable in the treatment of status asthmaticus]. Nihon Kyobu Shikkan Gakkai Zasshi. 1990 Jul;28(7):978–984. [PubMed]
  • Williams SJ, Parrish RW, Seaton A. Comparison of intravenous aminophylline and salbutamol in severe asthma. Br Med J. 1975 Dec 20;4(5998):685–685. [PMC free article] [PubMed]
  • Rossing TH, Fanta CH, McFadden ER., Jr Effect of outpatient treatment of asthma with beta agonists on the response to sympathomimetics in an emergency room. Am J Med. 1983 Nov;75(5):781–784. [PubMed]
  • Ruffin R, Bryant D, Burdon J, Marlin G, Mitchell C, O'Hehir R, Wilson J, Woolcock A, Webb S. Comparison of the effects of nebulized terbutaline with intravenous enprofylline in patients with acute asthma. Chest. 1988 Mar;93(3):510–514. [PubMed]
  • Self TH, Abou-Shala N, Burns R, Stewart CF, Ellis RF, Tsiu SJ, Kellermann AL. Inhaled albuterol and oral prednisone therapy in hospitalized adult asthmatics. Does aminophylline add any benefit? Chest. 1990 Dec;98(6):1317–1321. [PubMed]
  • Murphy DG, McDermott MF, Rydman RJ, Sloan EP, Zalenski RJ. Aminophylline in the treatment of acute asthma when beta 2-adrenergics and steroids are provided. Arch Intern Med. 1993 Aug 9;153(15):1784–1788. [PubMed]
  • Zainudin BM, Ismail O, Yusoff K. Effect of adding aminophylline infusion to nebulised salbutamol in severe acute asthma. Thorax. 1994 Mar;49(3):267–269. [PMC free article] [PubMed]
  • Josephson GW, MacKenzie EJ, Lietman PS, Gibson G. Emergency treatment of asthma. A comparison of two treatment regimens. JAMA. 1979 Aug 17;242(7):639–643. [PubMed]
  • Siegel D, Sheppard D, Gelb A, Weinberg PF. Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. Am Rev Respir Dis. 1985 Aug;132(2):283–286. [PubMed]
  • FREEDMAN BJ. Accidental adrenaline overdosage and its treatment with piperoxan. Lancet. 1955 Sep 17;269(6890):575–578. [PubMed]
  • McFadden ER., Jr Critical appraisal of the therapy of asthma--an idea whose time has come. Am Rev Respir Dis. 1986 May;133(5):723–724. [PubMed]
  • Salmeron S, Brochard L, Mal H, Tenaillon A, Henry-Amar M, Renon D, Duroux P, Simonneau G. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med. 1994 Jun;149(6):1466–1470. [PubMed]
  • Williams SJ, Winner SJ, Clark TJ. Comparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax. 1981 Aug;36(8):629–631. [PMC free article] [PubMed]
  • Bloomfield P, Carmichael J, Petrie GR, Jewell NP, Crompton GK. Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma. Br Med J. 1979 Mar 31;1(6167):848–850. [PMC free article] [PubMed]
  • May CS, Paterson JW, Spiro SG, Johnson AJ. Effect of intravenous injection of salbutamol in asthma. Br J Clin Pharmacol. 1975 Dec;2(6):495–501. [PubMed]
  • Crompton GK. Nebulized or intravenous beta 2 adrenoceptor agonist therapy in acute asthma? Eur Respir J. 1990 Feb;3(2):125–126. [PubMed]
  • Cheong B, Reynolds SR, Rajan G, Ward MJ. Intravenous beta agonist in severe acute asthma. BMJ. 1988 Aug 13;297(6646):448–450. [PMC free article] [PubMed]
  • Williams S, Seaton A. Intravenous or inhaled salbutamol in severe acute asthma? Thorax. 1977 Oct;32(5):555–558. [PMC free article] [PubMed]
  • Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993 Oct;21(10):1479–1486. [PubMed]
  • Colacone A, Wolkove N, Stern E, Afilalo M, Rosenthal TM, Kreisman H. Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest. 1990 Mar;97(3):693–697. [PubMed]
  • Britton J, Tattersfield A. Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma. Thorax. 1984 Aug;39(8):597–599. [PMC free article] [PubMed]
  • Robertson CF, Smith F, Beck R, Levison H. Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr. 1985 Apr;106(4):672–674. [PubMed]
  • Colacone A, Afilalo M, Wolkove N, Kreisman H. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest. 1993 Sep;104(3):835–841. [PubMed]
  • Fuglsang G, Pedersen S. Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis. 1986 Aug;69(2):109–113. [PubMed]
  • Salzman GA, Steele MT, Pribble JP, Elenbaas RM, Pyszczynski DR. Aerosolized metaproterenol in the treatment of asthmatics with severe airflow obstruction. Comparison of two delivery methods. Chest. 1989 May;95(5):1017–1020. [PubMed]
  • Idris AH, McDermott MF, Raucci JC, Morrabel A, McGorray S, Hendeles L. Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest. 1993 Mar;103(3):665–672. [PubMed]
  • Cayton RM, Webber B, Paterson JW, Clark TJ. A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma. Br J Dis Chest. 1978 Jul;72(3):222–224. [PubMed]
  • Turner JR, Corkery KJ, Eckman D, Gelb AM, Lipavsky A, Sheppard D. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest. 1988 Mar;93(3):476–481. [PubMed]
  • Tarala RA, Madsen BW, Paterson JW. Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma. Br J Clin Pharmacol. 1980 Oct;10(4):393–397. [PubMed]
  • Beasley CR, O'Donnell TV. Pear shaped spacer nebuhaler compared with nebulised solution for terbutaline administration in acute severe asthma. N Z Med J. 1985 Oct 9;98(788):854–855. [PubMed]
  • Morley TF, Marozsan E, Zappasodi SJ, Gordon R, Griesback R, Giudice JC. Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients. Chest. 1988 Dec;94(6):1205–1210. [PubMed]
  • Newhouse MT. Emergency department management of life-threatening asthma. Are nebulizers obsolete? Chest. 1993 Mar;103(3):661–663. [PubMed]
  • Benton G, Thomas RC, Nickerson BG, McQuitty JC, Okikawa J. Experience with a metered-dose inhaler with a spacer in the pediatric emergency department. Am J Dis Child. 1989 Jun;143(6):678–681. [PubMed]
  • Morgan MD, Singh BV, Frame MH, Williams SJ. Terbutaline aerosol given through pear spacer in acute severe asthma. Br Med J (Clin Res Ed) 1982 Sep 25;285(6345):849–850. [PMC free article] [PubMed]
  • Newhouse M, Dolovich M. Aerosol therapy: nebulizer vs metered dose inhaler. Chest. 1987 Jun;91(6):799–800. [PubMed]
  • Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital. Chest. 1992 Feb;101(2):305–308. [PubMed]
  • Summer W, Elston R, Tharpe L, Nelson S, Haponik EF. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. Arch Intern Med. 1989 Mar;149(3):618–623. [PubMed]
  • Jasper AC, Mohsenifar Z, Kahan S, Goldberg HS, Koerner SK. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest. 1987 Apr;91(4):614–618. [PubMed]
  • Summers QA, Tarala RA. Nebulized ipratropium in the treatment of acute asthma. Chest. 1990 Feb;97(2):425–429. [PubMed]
  • Rebuck AS, Chapman KR, Abboud R, Pare PD, Kreisman H, Wolkove N, Vickerson F. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med. 1987 Jan;82(1):59–64. [PubMed]
  • Bryant DH. Nebulized ipratropium bromide in the treatment of acute asthma. Chest. 1985 Jul;88(1):24–29. [PubMed]
  • Higgins RM, Stradling JR, Lane DJ. Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma? Chest. 1988 Oct;94(4):718–722. [PubMed]
  • O'Driscoll BR, Taylor RJ, Horsley MG, Chambers DK, Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet. 1989 Jun 24;1(8652):1418–1420. [PubMed]
  • Louw SJ, Goldin JG, Isaacs S. Relative efficacy of nebulised ipratropium bromide and fenoterol in acute severe asthma. S Afr Med J. 1990 Jan 6;77(1):24–26. [PubMed]
  • Bryant DH, Rogers P. Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma. Chest. 1992 Sep;102(3):742–747. [PubMed]
  • Leahy BC, Gomm SA, Allen SC. Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma. Br J Dis Chest. 1983 Apr;77(2):159–163. [PubMed]
  • Ward MJ, Fentem PH, Smith WH, Davies D. Ipratropium bromide in acute asthma. Br Med J (Clin Res Ed) 1981 Feb 21;282(6264):598–600. [PMC free article] [PubMed]
  • Gross NJ. The use of anticholinergic agents in the treatment of airways disease. Clin Chest Med. 1988 Dec;9(4):591–598. [PubMed]
  • Whyte KF, Gould GA, Jeffrey AA, Airlie MA, Flenley DC, Douglas NJ. Dose of nebulized ipratropium bromide in acute severe asthma. Respir Med. 1991 Nov;85(6):517–520. [PubMed]
  • Littenberg B. Aminophylline treatment in severe, acute asthma. A meta-analysis. JAMA. 1988 Mar 18;259(11):1678–1684. [PubMed]
  • Coleridge J, Cameron P, Epstein J, Teichtahl H. Intravenous aminophylline confers no benefit in acute asthma treated with intravenous steroids and inhaled bronchodilators. Aust N Z J Med. 1993 Aug;23(4):348–354. [PubMed]
  • Kelly HW, Murphy S. Should we stop using theophylline for the treatment of the hospitalized patient with status asthmaticus? DICP. 1989 Dec;23(12):995–998. [PubMed]
  • Huang D, O'Brien RG, Harman E, Aull L, Reents S, Visser J, Shieh G, Hendeles L. Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma? Ann Intern Med. 1993 Dec 15;119(12):1155–1160. [PubMed]
  • Wrenn K, Slovis CM, Murphy F, Greenberg RS. Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med. 1991 Aug 15;115(4):241–247. [PubMed]
  • L'Hommedieu CS, Arens JJ. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med. 1987 May;16(5):568–571. [PubMed]
  • White PF, Way WL, Trevor AJ. Ketamine--its pharmacology and therapeutic uses. Anesthesiology. 1982 Feb;56(2):119–136. [PubMed]
  • Corssen G, Gutierrez J, Reves JG, Huber FC., Jr Ketamine in the anesthetic management of asthmatic patients. Anesth Analg. 1972 Jul-Aug;51(4):588–596. [PubMed]
  • Betts EK, Parkin CE. Use of ketamine in an asthmatic child: a case report. Anesth Analg. 1971 May-Jun;50(3):420–421. [PubMed]
  • Hemming A, MacKenzie I, Finfer S. Response to ketamine in status asthmaticus resistant to maximal medical treatment. Thorax. 1994 Jan;49(1):90–91. [PMC free article] [PubMed]
  • Rock MJ, Reyes de la Rocha S, L'Hommedieu CS, Truemper E. Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med. 1986 May;14(5):514–516. [PubMed]
  • Strube PJ, Hallam PL. Ketamine by continuous infusion in status asthmaticus. Anaesthesia. 1986 Oct;41(10):1017–1019. [PubMed]
  • Sarma VJ. Use of ketamine in acute severe asthma. Acta Anaesthesiol Scand. 1992 Jan;36(1):106–107. [PubMed]
  • Fischer MM. Ketamine hydrochloride in severe bronchospasm. Anaesthesia. 1977 Sep;32(8):771–772. [PubMed]
  • Hedges JR, Dronen SC, Feero S, Hawkins S, Syverud SA, Shultz B. Succinylcholine-assisted intubations in prehospital care. Ann Emerg Med. 1988 May;17(5):469–472. [PubMed]
  • Thompson JD, Fish S, Ruiz E. Succinylcholine for endotracheal intubation. Ann Emerg Med. 1982 Oct;11(10):526–529. [PubMed]
  • Robertson CE, Steedman D, Sinclair CJ, Brown D, Malcolm-Smith N. Use of ether in life-threatening acute severe asthma. Lancet. 1985 Jan 26;1(8422):187–188. [PubMed]
  • Saulnier FF, Durocher AV, Deturck RA, Lefèbvre MC, Wattel FE. Respiratory and hemodynamic effects of halothane in status asthmaticus. Intensive Care Med. 1990;16(2):104–107. [PubMed]
  • Schwartz SH. Treatment of status asthmaticus with halothane. JAMA. 1984 May 25;251(20):2688–2689. [PubMed]
  • O'Rourke PP, Crone RK. Halothane in status asthmaticus. Crit Care Med. 1982 May;10(5):341–343. [PubMed]
  • Echeverria M, Gelb AW, Wexler HR, Ahmad D, Kenefick P. Enflurane and halothane in status asthmaticus. Chest. 1986 Jan;89(1):152–154. [PubMed]
  • Johnston RG, Noseworthy TW, Friesen EG, Yule HA, Shustack A. Isoflurane therapy for status asthmaticus in children and adults. Chest. 1990 Mar;97(3):698–701. [PubMed]
  • Bierman MI, Brown M, Muren O, Keenan RL, Glauser FL. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med. 1986 Sep;14(9):832–833. [PubMed]
  • Menitove SM, Goldring RM. Combined ventilator and bicarbonate strategy in the management of status asthmaticus. Am J Med. 1983 May;74(5):898–901. [PubMed]
  • Darioli R, Perret C. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis. 1984 Mar;129(3):385–387. [PubMed]
  • McFadden ER, Jr, Kiser R, DeGroot WJ. Acute bronchial asthma. Relations between clinical and physiologic manifestations. N Engl J Med. 1973 Feb 1;288(5):221–225. [PubMed]
  • Baumann UA, Haerdi E, Keller R. Relations between clinical signs and lung function in bronchial asthma: how is acute bronchial obstruction reflected in dyspnoea and wheezing? Respiration. 1986;50(4):294–300. [PubMed]
  • Carden DL, Nowak RM, Sarkar D, Tomlanovich MC. Vital signs including pulsus paradoxus in the assessment of acute bronchial asthma. Ann Emerg Med. 1983 Feb;12(2):80–83. [PubMed]
  • Kelsen SG, Kelsen DP, Fleeger BF, Jones RC, Rodman T. Emergency room assessment and treatment of patients with acute asthma. Adequacy of the conventional approach. Am J Med. 1978 Apr;64(4):622–628. [PubMed]
  • Nowak RM, Pensler MI, Sarkar DD, Anderson JA, Kvale PA, Ortiz AE, Tomlanovich MC. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med. 1982 Feb;11(2):64–69. [PubMed]
  • Worthington JR, Ahuja J. The value of pulmonary function tests in the management of acute asthma. CMAJ. 1989 Jan 15;140(2):153–156. [PMC free article] [PubMed]
  • Nowak RM, Gordon KR, Wroblewski DA, Tomlanovich MC, Kvale PA. Spirometric evaluation of acute bronchial asthma. JACEP. 1979 Jan;8(1):9–12. [PubMed]
  • Banner AS, Shah RS, Addington WW. Rapid prediction of need for hospitalization in acute asthma. JAMA. 1976 Mar 29;235(13):1337–1338. [PubMed]
  • Corre KA, Rothstein RJ. Assessing severity of adult asthma and need for hospitalization. Ann Emerg Med. 1985 Jan;14(1):45–52. [PubMed]
  • Crane J, Pearce N, Burgess C, Woodman K, Robson B, Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol. 1992 Aug;21(4):737–744. [PubMed]
  • Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. [PubMed]
  • Taylor DR, Sears MR, Herbison GP, Flannery EM, Print CG, Lake DC, Yates DM, Lucas MK, Li Q. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax. 1993 Feb;48(2):134–138. [PMC free article] [PubMed]
  • Ernst P, Habbick B, Suissa S, Hemmelgarn B, Cockcroft D, Buist AS, Horwitz RI, McNutt M, Spitzer WO. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis. 1993 Jul;148(1):75–79. [PubMed]
  • Fanta CH, Rossing TH, McFadden ER., Jr Glucocorticoids in acute asthma. A critical controlled trial. Am J Med. 1983 May;74(5):845–851. [PubMed]
  • Fiel SB, Swartz MA, Glanz K, Francis ME. Efficacy of short-term corticosteroid therapy in outpatient treatment of acute bronchial asthma. Am J Med. 1983 Aug;75(2):259–262. [PubMed]
  • Chapman KR, Verbeek PR, White JG, Rebuck AS. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med. 1991 Mar 21;324(12):788–794. [PubMed]
  • Rowe BH, Keller JL, Oxman AD. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med. 1992 Jul;10(4):301–310. [PubMed]
  • Stein LM, Cole RP. Early administration of corticosteroids in emergency room treatment of acute asthma. Ann Intern Med. 1990 Jun 1;112(11):822–827. [PubMed]
  • Littenberg B, Gluck EH. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med. 1986 Jan 16;314(3):150–152. [PubMed]
  • Schneider SM, Pipher A, Britton HL, Borok Z, Harcup CH. High-dose methylprednisolone as initial therapy in patients with acute bronchospasm. J Asthma. 1988;25(4):189–193. [PubMed]
  • Engel T, Dirksen A, Frølund L, Heinig JH, Svendsen UG, Pedersen BK, Weeke B. Methylprednisolone pulse therapy in acute severe asthma. A randomized, double-blind study. Allergy. 1990 Apr;45(3):224–230. [PubMed]
  • Ratto D, Alfaro C, Sipsey J, Glovsky MM, Sharma OP. Are intravenous corticosteroids required in status asthmaticus? JAMA. 1988 Jul 22;260(4):527–529. [PubMed]
  • Jónsson S, Kjartansson G, Gíslason D, Helgason H. Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline. Chest. 1988 Oct;94(4):723–726. [PubMed]
  • Harrison BD, Stokes TC, Hart GJ, Vaughan DA, Ali NJ, Robinson AA. Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet. 1986 Jan 25;1(8474):181–184. [PubMed]
  • Ellul-Micallef R, Fenech FF. Effect of intravenous prednisolone in asthmatics with diminished adrenergic responsiveness. Lancet. 1975 Dec 27;2(7948):1269–1271. [PubMed]
  • Britton MG, Collins JV, Brown D, Fairhurst NP, Lambert RG. High-dose corticosteroids in severe acute asthma. Br Med J. 1976 Jul 10;2(6027):73–74. [PMC free article] [PubMed]
  • Raimondi AC, Figueroa-Casas JC, Roncoroni AJ. Comparison between high and moderate doses of hydrocortisone in the treatment of status asthmaticus. Chest. 1986 Jun;89(6):832–835. [PubMed]
  • Tanaka RM, Santiago SM, Kuhn GJ, Williams RE, Klaustermeyer WB. Intravenous methylprednisolone in adults in status asthmaticus. Comparison of two dosages. Chest. 1982 Oct;82(4):438–440. [PubMed]
  • McFadden ER, Jr, Kiser R, deGroot WJ, Holmes B, Kiker R, Viser G. A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma. Am J Med. 1976 Jan;60(1):52–59. [PubMed]
  • Bowler SD, Mitchell CA, Armstrong JG. Corticosteroids in acute severe asthma: effectiveness of low doses. Thorax. 1992 Aug;47(8):584–587. [PMC free article] [PubMed]
  • Morell F, Orriols R, de Gracia J, Curull V, Pujol A. Controlled trial of intravenous corticosteroids in severe acute asthma. Thorax. 1992 Aug;47(8):588–591. [PMC free article] [PubMed]
  • Haskell RJ, Wong BM, Hansen JE. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med. 1983 Jul;143(7):1324–1327. [PubMed]
  • McFadden ER., Jr Dosages of corticosteroids in asthma. Am Rev Respir Dis. 1993 May;147(5):1306–1310. [PubMed]
  • Engel T, Heinig JH. Glucocorticosteroid therapy in acute severe asthma--a critical review. Eur Respir J. 1991 Jul;4(7):881–889. [PubMed]
  • Webb JR. Dose response of patients to oral corticosteroid treatment during exacerbations of asthma. Br Med J (Clin Res Ed) 1986 Apr 19;292(6527):1045–1047. [PMC free article] [PubMed]
  • O'Driscoll BR, Kalra S, Wilson M, Pickering CA, Carroll KB, Woodcock AA. Double-blind trial of steroid tapering in acute asthma. Lancet. 1993 Feb 6;341(8841):324–327. [PubMed]
  • Salmeron S, Guerin JC, Godard P, Renon D, Henry-Amar M, Duroux P, Taytard A. High doses of inhaled corticosteroids in unstable chronic asthma. A multicenter, double-blind, placebo-controlled study. Am Rev Respir Dis. 1989 Jul;140(1):167–171. [PubMed]
  • Clark NM. Asthma self-management education. Research and implications for clinical practice. Chest. 1989 May;95(5):1110–1113. [PubMed]
  • Bailey WC, Richards JM, Jr, Brooks CM, Soong SJ, Windsor RA, Manzella BA. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990 Aug;150(8):1664–1668. [PubMed]
  • Charlton I, Charlton G, Broomfield J, Mullee MA. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ. 1990 Dec 15;301(6765):1355–1359. [PMC free article] [PubMed]
  • Mayo PH, Richman J, Harris HW. Results of a program to reduce admissions for adult asthma. Ann Intern Med. 1990 Jun 1;112(11):864–871. [PubMed]
  • FitzGerald JM, Swan D, Turner MO. The role of asthma education. CMAJ. 1992 Sep 15;147(6):855–856. [PMC free article] [PubMed]

Articles from CMAJ : Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association